Prothena Corp Public (PRTA) Other Operating Expenses (2018 - 2026)
Prothena Corp Public (PRTA) posted quarterly Other Operating Expenses of -$4.2 million for Q1 2026, down 41.09% quarter-over-quarter from -$3.0 million in Q4 2025.
Prothena Corp Public (PRTA) Other Operating Expenses (2018 - 2026) Analysis & Trends
Prothena Corp Public's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$4.2 million for Q1 2026.
- In Q1 2026, Other Operating Expenses changed N/A year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at $25.8 million (changed N/A YoY), while the FY2025 annual figure was $30.1 million, changed N/A from the prior year.
- Other Operating Expenses for Q1 2026 stood at -$4.2 million, down from -$3.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $32.6 million in Q2 2025, with the low at -$4.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.41 Mn |
| Mar 31, 2026 | -4.24 Mn |
| Dec 31, 2025 | -3.01 Mn |
| Sep 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 32.61 Mn |
| Mar 31, 2019 | -61,000.00 |
| Dec 31, 2018 | -1.59 Mn |
| Sep 30, 2018 | -3.17 Mn |
| Jun 30, 2018 | 20.90 Mn |